Buscar

Estamos realizando la búsqueda. Por favor, espere...

 Detalle_Publicacion

Systemic treatment in sarcoidosis: Experience over two decades

Abstract: Objective: The aim of this study was to evaluate the frequency of systemic treatment in a cohort of sarcoidosis patients and identify presenting clinical features as predictive factors of the need for systemic immunosuppressive therapy. Methods: Retrospective study of 342 patients diagnosed and followed-up from January 1999 to December 2019 in a University Hospital in Northern Spain. The diagnosis of sarcoidosis was established according to ATS/ERS/WASOG criteria. A comparative analysis was performed between treated and untreated patients. Predictive factors of treatment prescription according to initial clinical manifestations were identified (multivariate analysis). Results: Mean age at diagnosis was 47.7±15.1 years, with a slight female predominance (51.8%) and Caucasian majority (94.2%). The main clinical manifestation was thoracic involvement (88.3%). Extrathoracic manifestations were detected in 68.4% cases, mainly cutaneous (34.2%), articular (27.8%) and ocular (17.8%). A total of 207 (60.5%) patients required systemic treatment. Glucocorticoid therapy was the most widely used (60.5%). Conventional immunosuppressive therapy in 25.4%, more frequently MTX (21.9%). Biologic therapy was prescribed in 12.9%, especially adalimumab (9.1%). Male gender (OR: 1.65; 95%CI: 1.06-2.56), intrathoracic (OR: 2.41; 95%CI: 1.22-4.76), ocular (OR: 4.14; 95%CI: 2.01-8.52), parotid (OR: 1.60; 95%CI: 1.39-1.94), neurological (OR: 5.00; 95%CI: 1.68-14.84), and renal (OR: 1.59; 95%CI: 1.38-1.94) involvement were identified as risk factors associated with the need of systemic treatment. Conclusion: Most patients (60.5%) of sarcoidosis in our series required systemic therapy. An association between certain characteristics at initial presentation (male gender, lung, ocular, parotid, neurological and renal involvement) and the need of systemic treatment was identified.

Otras publicaciones de la misma revista o congreso con autores/as de la Universidad de Cantabria

 Fuente: European Journal of Internal Medicine, 2023, 108, 60-67

Editorial: Elsevier

 Año de publicación: 2023

Nº de páginas: 8

Tipo de publicación: Artículo de Revista

 DOI: 10.1016/j.ejim.2022.11.020

ISSN: 0953-6205,1879-0828

Url de la publicación: https://doi.org/10.1016/j.ejim.2022.11.020

Autoría

FERNÁNDEZ-RAMÓN, RAÚL

GAITÁN-VALDIZÁN, JORGE J

GONZÁLEZ-MAZÓN, IÑIGO

SÁNCHEZ-BILBAO, LARA

MARTÍN-VARILLAS, JOSÉ L

MARTÍNEZ-LÓPEZ, DAVID

DEMETRIO-PABLO, ROSALÍA

FERRAZ-AMARO, IVÁN

CASTAÑEDA, SANTOS